BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Applied DNA Announces Selected Preliminary Unaudited Fiscal Fourth Quarter and Year End Results

  Revenues increased 13% to $4.8 million as compared to $4.2 million in the prior fiscal year.

  December 15, 2017

   · 

  6 min read
• Biotech Bay

  Pulse Biosciences Grants Equity Inducement Awards to New Employees

  The options have an exercise price of $24.78 per share, which is equal to the closing price of Pulse Biosciences common stock on December 15, 2017.

  December 15, 2017

   · 

  2 min read
• Lone Star Bio

  ESSA Announces Filing of Prospectus Supplement and an Update to Previously Announced Equity Offering

  The Company intends to issue up to 75,000,000 units of the Company at a price of US$0.20 per Unit for aggregate gross proceeds of up to US$15 million.

  December 15, 2017

   · 

  6 min read
• Drug Development

  ASIT Biotech Reviews the Efficacy Results of gp-ASIT+

  The results presented to the EAACI show that over the course of the whole pollen season, gp-ASIT+ resulted in an average reduction in the combined score of 17.9% for the entire study population, close to the threshold of 20% required by the registration authorities.

  December 15, 2017

   · 

  2 min read
• Genetown

  TESARO Announces Availability of ZEJULA (niraparib) for Women With Recurrent Ovarian Cancer in Germany

  ZEJULA is the first once-daily, oral PARP inhibitor to be approved in Europe that does not require BRCA mutation or biomarker testing.

  December 15, 2017

   · 

  8 min read
• Drug Development

  Espero BioPharma Provides Corporate Update and 2018 Objectives

  Espero BioPharma today announced a strategic update on its clinical and regulatory strategies for tecarfarin, an oral anticoagulant.

  December 15, 2017

   · 

  6 min read
• Business

  Esperion Announces the Appointment of Jeffrey Berkowitz to Board of Directors

  Mr. Berkowitz is the former executive vice president of Optum.

  December 15, 2017

   · 

  6 min read
• Pharm Country

  PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) of 10,000 Shares of Its Common Stock

  The awards were made pursuant to the NASDAQ inducement grant exception as a component of the new hires’ employment compensation.

  December 15, 2017

   · 

  1 min read
• BioMidwest

  InstruSafe by Summit Medical to Launch Two New Surgical Trays for Senhance Surgical Robotic System Instrumentation

  Summit Medical announced the release of two new trays to the market. The two new trays — an instrument tray and an endoscopic adapter tray — have both been designed in collaboration with and validated specifically for the Senhance Surgical Robotic System instrumentation.

  December 15, 2017

   · 

  1 min read
• Policy

  Celltrion Receives Positive CHMP Opinion for Herzuma for Trastuzumab Biosimilar

  The CHMP’s opinion will now be sent to the European Commission (EC) for final review.

  December 15, 2017

   · 

  2 min read